AngioDynamics (ANGO) Revenue & Revenue Breakdown
AngioDynamics Revenue Highlights
Latest Revenue (Y)
$303.91M
Latest Revenue (Q)
$75.18M
Main Segment (Y)
Med Device
Main Geography (Y)
UNITED STATES
AngioDynamics Revenue by Period
AngioDynamics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-05-31 | $303.91M | -10.28% |
| 2023-05-31 | $338.75M | 7.13% |
| 2022-05-31 | $316.22M | 8.66% |
| 2021-05-31 | $291.01M | 10.17% |
| 2020-05-31 | $264.16M | -26.52% |
| 2019-05-31 | $359.48M | 4.41% |
| 2018-05-31 | $344.29M | -1.53% |
| 2017-05-31 | $349.64M | -1.14% |
| 2016-05-31 | $353.69M | -0.92% |
| 2015-05-31 | $356.97M | 0.71% |
| 2014-05-31 | $354.45M | 3.63% |
| 2013-05-31 | $342.03M | 54.21% |
| 2012-05-31 | $221.79M | 2.70% |
| 2011-05-31 | $215.96M | -0.04% |
| 2010-05-31 | $216.03M | 10.76% |
| 2009-05-31 | $195.05M | 17.15% |
| 2008-05-31 | $166.50M | 48.36% |
| 2007-05-31 | $112.23M | 43.05% |
| 2006-06-03 | $78.45M | 30.12% |
| 2005-05-28 | $60.29M | 22.90% |
| 2004-05-29 | $49.05M | 27.63% |
| 2003-05-31 | $38.43M | 24.42% |
| 2002-05-31 | $30.89M | 32.06% |
| 2001-05-31 | $23.39M | - |
AngioDynamics generated $303.91M in revenue during NA 2024, up -10.28% compared to the previous quarter, and up 84.54% compared to the same period a year ago.
AngioDynamics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-02-29 | $75.18M | -4.92% |
| 2023-11-30 | $79.07M | 0.50% |
| 2023-08-31 | $78.68M | -13.61% |
| 2023-05-31 | $91.07M | 12.84% |
| 2023-02-28 | $80.71M | -5.52% |
| 2022-11-30 | $85.43M | 4.77% |
| 2022-08-31 | $81.54M | -6.28% |
| 2022-05-31 | $87.00M | 17.61% |
| 2022-02-28 | $73.97M | -5.51% |
| 2021-11-30 | $78.28M | 1.70% |
| 2021-08-31 | $76.97M | 0.17% |
| 2021-05-31 | $76.84M | 7.95% |
| 2021-02-28 | $71.18M | -2.18% |
| 2020-11-30 | $72.77M | 3.64% |
| 2020-08-31 | $70.22M | 20.37% |
| 2020-05-31 | $58.33M | -16.41% |
| 2020-02-29 | $69.78M | -0.32% |
| 2019-11-30 | $70.00M | 6.00% |
| 2019-08-31 | $66.04M | -31.42% |
| 2019-05-31 | $96.30M | 11.53% |
| 2019-02-28 | $86.34M | -5.64% |
| 2018-11-30 | $91.50M | 7.22% |
| 2018-08-31 | $85.34M | -3.37% |
| 2018-05-31 | $88.32M | 5.33% |
| 2018-02-28 | $83.85M | -3.29% |
| 2017-11-30 | $86.71M | 1.52% |
| 2017-08-31 | $85.41M | -1.73% |
| 2017-05-31 | $86.91M | 1.53% |
| 2017-02-28 | $85.60M | -3.85% |
| 2016-11-30 | $89.03M | 1.06% |
| 2016-08-31 | $88.10M | -5.65% |
| 2016-05-31 | $93.37M | 6.85% |
| 2016-02-29 | $87.38M | -2.07% |
| 2015-11-30 | $89.23M | 6.61% |
| 2015-08-31 | $83.70M | -7.91% |
| 2015-05-31 | $90.90M | 4.97% |
| 2015-02-28 | $86.60M | -6.03% |
| 2014-11-30 | $92.15M | 5.52% |
| 2014-08-31 | $87.33M | -7.16% |
| 2014-05-31 | $94.06M | 6.66% |
| 2014-02-28 | $88.19M | -0.48% |
| 2013-11-30 | $88.62M | 6.03% |
| 2013-08-31 | $83.58M | -7.17% |
| 2013-05-31 | $90.03M | 10.37% |
| 2013-02-28 | $81.57M | -6.25% |
| 2012-11-30 | $87.01M | 4.32% |
| 2012-08-31 | $83.41M | 44.58% |
| 2012-05-31 | $57.69M | 11.87% |
| 2012-02-29 | $51.57M | -11.24% |
| 2011-11-30 | $58.10M | 6.74% |
| 2011-08-31 | $54.43M | -3.19% |
| 2011-05-31 | $56.22M | 2.88% |
| 2011-02-28 | $54.65M | 2.39% |
| 2010-11-30 | $53.37M | 3.62% |
| 2010-08-31 | $51.51M | -14.55% |
| 2010-05-31 | $60.28M | 15.46% |
| 2010-02-28 | $52.21M | -2.34% |
| 2009-11-30 | $53.46M | 6.72% |
| 2009-08-31 | $50.09M | -5.16% |
| 2009-05-31 | $52.82M | 6.82% |
| 2009-02-28 | $49.45M | 2.03% |
| 2008-11-30 | $48.46M | 9.34% |
| 2008-08-31 | $44.32M | -5.20% |
| 2008-05-31 | $46.75M | 14.80% |
| 2008-02-29 | $40.73M | - |
AngioDynamics generated $75.18M in revenue during Q3 2024, up -4.92% compared to the previous quarter, and up 88.01% compared to the same period a year ago.
AngioDynamics Revenue Breakdown
AngioDynamics Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | May 24 | May 22 | May 21 | May 20 | May 19 |
|---|---|---|---|---|---|
| Med Device | $197.51M | $237.50M | - | - | - |
| Med Tech | $106.40M | $78.72M | - | - | - |
| Endovascular Therapies | - | - | $135.08M | - | - |
| Oncology Surgery | - | - | $54.62M | $57.15M | - |
| Access | - | - | - | $94.30M | $94.73M |
| Peripheral Vascular | - | - | - | $112.71M | - |
AngioDynamics's latest annual revenue breakdown by segment (product or service), as of May 24: Med Device (64.99%), and Med Tech (35.01%).
Quarterly Revenue by Product
| Product/Service | May 24 | Feb 24 | Nov 23 | Aug 23 | May 22 | Feb 22 | Nov 21 | Aug 21 |
|---|---|---|---|---|---|---|---|---|
| Med Tech | $29.34M | $25.84M | $25.36M | $25.86M | $22.60M | $19.61M | $18.89M | $17.62M |
| Med Device | $41.64M | $49.34M | $53.71M | $52.82M | $64.40M | $54.36M | $59.39M | $59.35M |
AngioDynamics's latest quarterly revenue breakdown by segment (product or service), as of May 24: Med Device (58.67%), and Med Tech (41.33%).
AngioDynamics Revenue Breakdown by Country
Annual Revenue by Country
| Country | May 24 | May 23 | May 22 | May 21 | May 20 |
|---|---|---|---|---|---|
| International | $52.43M | - | - | - | - |
| UNITED STATES | $251.49M | $84.33M | $146.88M | $121.43M | $98.97M |
| Non-US | - | $12.36M | $14.04M | $13.65M | $13.74M |
AngioDynamics's latest annual revenue breakdown by geography, as of May 24: UNITED STATES (82.75%), and International (17.25%).
Quarterly Revenue by Country
| Country | May 24 | Feb 24 | Nov 23 | Aug 23 | May 23 | Feb 23 | Nov 22 | Aug 22 | May 22 | Feb 22 | Nov 21 | Aug 21 | May 21 | Feb 21 | Nov 20 | Aug 20 | May 20 | Feb 20 | Nov 19 | Aug 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| UNITED STATES | $60.74M | $62.34M | $64.00M | $64.40M | $22.96M | $20.38M | $20.55M | $20.44M | $21.87M | $19.48M | $20.70M | $20.48M | $34.23M | $29.53M | $30.69M | $26.98M | $18.90M | $26.79M | $27.60M | $25.68M |
| Non-US | - | $12.84M | $15.07M | $14.28M | $3.54M | $2.49M | $3.95M | $2.38M | $4.86M | $3.95M | $4.37M | $4.48M | $3.84M | $3.72M | $3.21M | $2.88M | $3.19M | $3.76M | $3.55M | $3.24M |
AngioDynamics's latest quarterly revenue breakdown by geography, as of May 24: UNITED STATES (100.00%).
AngioDynamics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| COO | Cooper Companies | $3.59B | $1.00B |
| ATR | AptarGroup | $3.49B | $910.06M |
| NVST | Envista | $2.57B | $623.60M |
| ICUI | ICU Medical | $2.26B | $596.46M |
| HAE | Haemonetics | $1.31B | $336.17M |
| MMSI | Merit Medical Systems | $1.26B | $338.00M |
| ATRC | AtriCure | $399.25M | $116.27M |
| ANGO | AngioDynamics | $303.91M | $75.18M |
| NSTG | NanoString | $127.26M | $48.09M |
| AKYA | Akoya Biosciences | $96.63M | $23.16M |
| KRMD | KORU Medical Systems | $28.52M | $8.20M |
| ATRI | Atrion | - | $48.77M |
ANGO Revenue FAQ
What is AngioDynamics’s yearly revenue?
AngioDynamics's yearly revenue for 2024 was $303.91M, representing a decrease of -10.28% compared to 2023. The company's yearly revenue for 2023 was $338.75M, representing an increase of 7.13% compared to 2022. ANGO's yearly revenue for 2022 was $316.22M, representing an increase of 8.66% compared to 2021.
What is AngioDynamics’s quarterly revenue?
AngioDynamics's quarterly revenue for Q3 2024 was $75.18M, a -4.92% decrease from the previous quarter (Q2 2024), and a -6.85% decrease year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $79.07M, a 0.50% increase from the previous quarter (Q1 2024), and a -7.44% decrease year-over-year (Q2 2023). ANGO's quarterly revenue for Q1 2024 was $78.68M, a -13.61% decrease from the previous quarter (Q4 2023), and a -3.51% decrease year-over-year (Q1 2023).
What is AngioDynamics’s revenue growth rate?
AngioDynamics's revenue growth rate for the last 3 years (2022-2024) was -3.89%, and for the last 5 years (2020-2024) was 15.05%.
What are AngioDynamics’s revenue streams?
AngioDynamics's revenue streams in y 24 are Med Device, and Med Tech. Med Device generated $197.51M in revenue, accounting 64.99% of the company's total revenue, down -16.84% year-over-year. Med Tech generated $106.4M in revenue, accounting 35.01% of the company's total revenue, up 35.17% year-over-year.
What is AngioDynamics’s main source of revenue?
For the fiscal year ending May 24, the largest source of revenue of AngioDynamics was Med Device. This segment made a revenue of $197.51M, representing 64.99% of the company's total revenue.